CDKN3 and esophageal squamous cell carcinoma: In addition, the study of Cyclin-dependent kinase inhibitor-3 (CDKN3) revealed that overexpression of CDKN3 promoted cell proliferation, migration, and invasion in esophageal squamous cell carcinoma (Liu J. et al., 2019).